Rockefeller Capital Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-861
| Closed | -$187K | – | 2359 |
|
|
2022
Q4 | $187K | Sell |
861
-211
| -20% | -$45.8K | ﹤0.01% | 1697 |
|
|
2022
Q3 | $210K | Sell |
1,072
-205
| -16% | -$40.2K | ﹤0.01% | 1627 |
|
|
2022
Q2 | $273K | Buy |
1,277
+225
| +21% | +$48.1K | ﹤0.01% | 1502 |
|
|
2022
Q1 | $297K | Sell |
1,052
-1,082
| -51% | -$305K | ﹤0.01% | 1533 |
|
|
2021
Q4 | $803K | Sell |
2,134
-371
| -15% | -$140K | ﹤0.01% | 1130 |
|
|
2021
Q3 | $1.03M | Buy |
2,505
+194
| +8% | +$80K | 0.01% | 993 |
|
|
2021
Q2 | $854K | Buy |
2,311
+152
| +7% | +$56.2K | ﹤0.01% | 986 |
|
|
2021
Q1 | $625K | Buy |
2,159
+1,721
| +393% | +$498K | ﹤0.01% | 953 |
|
|
2020
Q4 | $109K | Buy |
438
+45
| +11% | +$11.2K | ﹤0.01% | 1404 |
|
|
2020
Q3 | $88K | Sell |
393
-6
| -2% | -$1.34K | ﹤0.01% | 1304 |
|
|
2020
Q2 | $69K | Sell |
399
-77
| -16% | -$13.3K | ﹤0.01% | 1311 |
|
|
2020
Q1 | $60K | Buy |
476
+88
| +23% | +$11.1K | ﹤0.01% | 1181 |
|
|
2019
Q4 | $60K | Sell |
388
-542
| -58% | -$83.8K | ﹤0.01% | 1102 |
|
|
2019
Q3 | $123K | Buy |
930
+575
| +162% | +$76K | ﹤0.01% | 733 |
|
|
2019
Q2 | $50K | Sell |
355
-187
| -35% | -$26.3K | ﹤0.01% | 812 |
|
|
2019
Q1 | $79K | Buy |
542
+289
| +114% | +$42.1K | ﹤0.01% | 812 |
|
|
2018
Q4 | $29K | Hold |
253
| – | – | ﹤0.01% | 578 |
|
|
2018
Q3 | $34K | Hold |
253
| – | – | ﹤0.01% | 464 |
|
|
2018
Q2 | $28K | Hold |
253
| – | – | ﹤0.01% | 497 |
|
|
2018
Q1 | $27K | Buy |
+253
| New | +$27K | ﹤0.01% | 452 |
|